BG
IDYA icon

Bellevue Group’s IDEAYA Biosciences IDYA Stock Holding History

Bellevue Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,942
Closed -$171K – 175
2025
Q4 		$171K Buy
+4,942
New +$158K ﹤0.01% 156
2024
Q4 		– Sell
-7,200
Closed -$228K – 168
2024
Q3 		$228K Buy
7,200
+1,500
+26% +$56.9K ﹤0.01% 143
2024
Q2 		$200K Buy
5,700
+2,400
+73% +$95K ﹤0.01% 147
2024
Q1 		$145K Buy
+3,300
New +$142K ﹤0.01% 158
2022
Q2 		– Sell
-46,200
Closed -$517K – 177
2022
Q1 		$517K Sell
46,200
-800
-2% -$11.8K 0.01% 155
2021
Q4 		$1.11M Buy
+47,000
New +$1.09M 0.01% 153

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bellevue Group's IDYA Position: Q1 2026 in Review

Bellevue Group sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 4,942 shares — an estimated $171K sold.

Bellevue Group first reported a position in IDYA in Q4 2021 and held it in 6 quarters. The position peaked at $1.11M in Q4 2021. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Bellevue Group reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bellevue Group sold 4,942 IDEAYA Biosciences shares in Q1 2026, an estimated $171K.
  • Bellevue Group first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 6 quarters.
  • Bellevue Group's IDEAYA Biosciences position peaked at $1.11M in Q4 2021.
  • 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.